Literature DB >> 28068564

Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease.

William C Kreisl1, Chul Hyoung Lyoo2, Jeih-San Liow2, Joseph Snow3, Emily Page2, Kimberly J Jenko2, Cheryl L Morse2, Sami S Zoghbi2, Victor W Pike2, R Scott Turner4, Robert B Innis2.   

Abstract

We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa, a marker of microglial activation, that is distinct from that in patients with amnestic presentation of Alzheimer's disease (AD). Eleven PCA patients, 11 amnestic AD patients, and 15 age-matched controls underwent positron emission tomography with 11C-PBR28 to measure translocator protein 18 kDa. PCA patients showed greater 11C-PBR28 binding than controls in occipital, posterior parietal, and temporal regions. In contrast, amnestic AD patients showed greater 11C-PBR28 binding in inferior and medial temporal cortex. Increased 11C-PBR28 binding overlapped with reduced cortical volume for both PCA and amnestic AD patients, and with areas of reduced glucose metabolism in PCA patients. While both patient groups showed diffuse amyloid binding, PCA patients showed greater binding than amnestic AD patients in bilateral occipital cortex. These results suggest that microglial activation is closely associated with neurodegeneration across different subtypes of AD. Published by Elsevier Inc.

Entities:  

Keywords:  Alzheimer's disease; Neuroinflammation; PET imaging

Mesh:

Substances:

Year:  2016        PMID: 28068564      PMCID: PMC5381519          DOI: 10.1016/j.neurobiolaging.2016.12.006

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  35 in total

1.  Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.

Authors:  Brian J Lopresti; William E Klunk; Chester A Mathis; Jessica A Hoge; Scott K Ziolko; Xueling Lu; Carolyn C Meltzer; Kurt Schimmel; Nicholas D Tsopelas; Steven T DeKosky; Julie C Price
Journal:  J Nucl Med       Date:  2005-12       Impact factor: 10.057

2.  Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.

Authors:  Paul Edison; Hilary A Archer; Alexander Gerhard; Rainer Hinz; Nicola Pavese; Federico E Turkheimer; Alexander Hammers; Yen Fong Tai; Nick Fox; Angus Kennedy; Martin Rossor; David J Brooks
Journal:  Neurobiol Dis       Date:  2008-08-15       Impact factor: 5.996

3.  Posterior cortical atrophy with [11C] Pittsburgh compound B accumulation in the primary visual cortex.

Authors:  Taiki Kambe; Yumiko Motoi; Kenji Ishii; Nobutaka Hattori
Journal:  J Neurol       Date:  2010-03       Impact factor: 4.849

4.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

5.  Posterior cortical atrophy: variant of Alzheimer's disease? A case series with PET findings.

Authors:  Klaus Schmidtke; Michael Hüll; Jochen Talazko
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

6.  CSF-tau and CSF-Abeta(1-42) in posterior cortical atrophy.

Authors:  Thomas P Baumann; Hüseyin Duyar; Marc Sollberger; Jens Kuhle; Axel Regeniter; Baltazar Gomez-Mancilla; Klaus Schmidtke; Andreas U Monsch
Journal:  Dement Geriatr Cogn Disord       Date:  2010-07-01       Impact factor: 2.959

7.  In vivo demonstration of amyloid burden in posterior cortical atrophy: a case series with PET and CSF findings.

Authors:  Maïté Formaglio; Nicolas Costes; Jérémie Seguin; Yannick Tholance; Didier Le Bars; Isabelle Roullet-Solignac; Bernadette Mercier; Pierre Krolak-Salmon; Alain Vighetto
Journal:  J Neurol       Date:  2011-04-10       Impact factor: 4.849

8.  Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution.

Authors:  M H Rosenbloom; A Alkalay; N Agarwal; S L Baker; J P O'Neil; M Janabi; I V Yen; M Growdon; J Jang; C Madison; E C Mormino; H J Rosen; M L Gorno-Tempini; M W Weiner; B L Miller; W J Jagust; G D Rabinovici
Journal:  Neurology       Date:  2011-04-27       Impact factor: 9.910

9.  Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid-beta accumulation.

Authors:  Olli Tenovuo; Nina Kemppainen; Sargo Aalto; Kjell Någren; Juha O Rinne
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

10.  The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET.

Authors:  P J Nestor; D Caine; T D Fryer; J Clarke; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

View more
  17 in total

1.  Cognitive tests aid in clinical differentiation of Alzheimer's disease versus Alzheimer's disease with Lewy body disease: Evidence from a pathological study.

Authors:  Martina Azar; Silvia Chapman; Yian Gu; James B Leverenz; Yaakov Stern; Stephanie Cosentino
Journal:  Alzheimers Dement       Date:  2020-06-19       Impact factor: 21.566

Review 2.  In vivo PET imaging of neuroinflammation in Alzheimer's disease.

Authors:  Julien Lagarde; Marie Sarazin; Michel Bottlaender
Journal:  J Neural Transm (Vienna)       Date:  2017-05-17       Impact factor: 3.575

3.  PET Imaging of Human Brown Adipose Tissue with the TSPO Tracer [11C]PBR28.

Authors:  Chongzhao Ran; Daniel S Albrecht; Miriam A Bredella; Jing Yang; Jian Yang; Steven H Liang; Aaron M Cypess; Marco L Loggia; Nazem Atassi; Anna Moore
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

4.  Building a database for brain 18 kDa translocator protein imaged using [11C]PBR28 in healthy subjects.

Authors:  Soumen Paul; Evan Gallagher; Jeih-San Liow; Sanche Mabins; Katharine Henry; Sami S Zoghbi; Roger N Gunn; William C Kreisl; Erica M Richards; Paolo Zanotti-Fregonara; Cheryl L Morse; Jinsoo Hong; Aneta Kowalski; Victor W Pike; Robert B Innis; Masahiro Fujita
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-11       Impact factor: 6.200

Review 5.  New insights into atypical Alzheimer's disease in the era of biomarkers.

Authors:  Jonathan Graff-Radford; Keir X X Yong; Liana G Apostolova; Femke H Bouwman; Maria Carrillo; Bradford C Dickerson; Gil D Rabinovici; Jonathan M Schott; David T Jones; Melissa E Murray
Journal:  Lancet Neurol       Date:  2021-03       Impact factor: 44.182

Review 6.  PET imaging of neuroinflammation in neurological disorders.

Authors:  William C Kreisl; Min-Jeong Kim; Jennifer M Coughlin; Ioline D Henter; David R Owen; Robert B Innis
Journal:  Lancet Neurol       Date:  2020-11       Impact factor: 44.182

7.  Microglial activation, but not tau pathology, is independently associated with amyloid positivity and memory impairment.

Authors:  James Zou; Sha Tao; Aubrey Johnson; Zeljko Tomljanovic; Krista Polly; Julia Klein; Qolamreza R Razlighi; Adam M Brickman; Seonjoo Lee; Yaakov Stern; William Charles Kreisl
Journal:  Neurobiol Aging       Date:  2019-09-29       Impact factor: 5.133

Review 8.  Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging.

Authors:  Chiara Cerami; Leonardo Iaccarino; Daniela Perani
Journal:  Int J Mol Sci       Date:  2017-05-05       Impact factor: 5.923

Review 9.  In vivo Imaging of Glial Activation in Alzheimer's Disease.

Authors:  Paul Edison; Cornelius K Donat; Magdalena Sastre
Journal:  Front Neurol       Date:  2018-08-07       Impact factor: 4.003

Review 10.  Visual Dysfunction in Posterior Cortical Atrophy.

Authors:  Mari N Maia da Silva; Rebecca S Millington; Holly Bridge; Merle James-Galton; Gordon T Plant
Journal:  Front Neurol       Date:  2017-08-16       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.